Apolipoprotein B gene polymorphisms and serum lipids: Meta-analysis of the role of genetic variation in responsiveness to diet

American Journal of Clinical Nutrition

Volumn 71, Issue 3, 2000, Pages 713-724

  Rantala, Maire ^a   Rantala, Tapio T ^b   Savolainen, Markku J ^b   Friedlander, Yechiel ^b   Kesäniemi, Y Antero ^b  

^a UNIVERSITY OF OULU   (Finland)

^b NONE

Author keywords

Apolipoprotein B; Cholesterol; Diet; Human; Meta analysis; Plasma lipids; Polymorphism; Restriction endonuclease; Restriction fragment length polymorphism; Restriction site polymorphism

Indexed keywords

APOLIPOPROTEIN B; RESTRICTION ENDONUCLEASE;

ADULT; ANALYTIC METHOD; ARTICLE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; DIETARY INTAKE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; META ANALYSIS; PROTEIN DIET; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE; STIMULUS RESPONSE;

EID: 0033996748     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.3.713     Document Type: Article

References (71)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971;74:1-12.
2. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986;2:933-6.
3. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 1983;3:187-98.
4. Katan MB, van Gastel AC, de Rover CM, van Montfort MA, Knuiman JT. Differences in individual responsiveness of serum cholesterol to fat-modified diets in man. Eur J Clin Invest 1988;18: 644-7.
5. Kesäniemi YA, Savolainen MJ, Uusitupa M, Sarkkinen E, Rantala M, Kervinen K. Apolipoprotein E phenotypes and response to dietary fat and cholesterol. In: Bray GA, Ryan DH, eds. Nutrition, genetics, and heart disease. Baton Rouge, LA: Lousiana State University Press, 1996:379-87.
6. Savolainen MJ, Rantala M, Kervinen K, et al. Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 1991;86:145-52.
7. Xu CF, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphries SE, Talmud PJ. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genet Epidemiol 1990;7:261-75.
8. Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A. Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 1992;86:849-57.
9. Sarkkinen ES, Uusitupa MI, Pietinen P, et al. Long-term effects of three fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 1994;105:9-23.
10. Zambon D, Ros E, Casals E, Sanllehy C, Bertomeu A, Campero I. Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. Am J Clin Nutr 1995;61:141-8.
11. Martin LJ, Connelly PW, Nancoo D, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 993;34:437-46.
12. Jones PJ, Main BF, Frohlich JJ. Response of cholesterol synthesis to cholesterol feeding in men with different apolipoprotein E genotypes. Metabolism 1993;42:1065-71
13. Glatz JF, Demacker PNM, Turner PR, Katan MB. Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutr Metab Cardiovasc Dis 1991;1:13-7.
14. Marshall JA, Kamboh MI, Bessesen DH, Hoag S; Hamman RF, Ferrell RE. Associations between dietary factors and serum lipids by apolipoprotein E polymorphism. Am J Clin Nutr 1996;63: 87-95.
15. Lehtimäki T, Moilanen T, Solakivi T, Laippala P, Ehnholm C. Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann Med 1992; 24:61-6.
16. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 1992;33:1361-71.
17. Mänttäri M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991;40:217-21.
18. Tikkanen MJ, Huttunen JK, Ehnholm C, Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high-fat diet. Arteriosclerosis 1990;10:285-8.
19. Lopez-Miranda J, Ordovas JM, Mata P, et al. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 1994;35:1965-75.
20. Gylling H, Kontula K, Koivisto UM, Miettinen HE, Miettinen TA. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 1997;17:38-44.
21. Miettinen TA, Gylling H, Vanhanen H, Ollus A. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 1992;12:1044-52.
22. Glatz JF, Turner PR, Katan MB, Stalenhoef AF, Lewis B. Hypo-and hyperresponse of serum cholesterol level and low density lipoprotein production and degradation to dietary cholesterol in man. Ann N Y Acad Sci 1993;676:163-79.
23. Berg K. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 1986;30:515-20.
24. Law A, Wallis SC, Powell LM, et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1986;1:1301-3.
25. Talmud PJ, Barni N, Kessling AM, et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo-and hyperlipidaemic individuals. Atherosclerosis 1987;67:81-9.
26. Aalto-Setälä K, Gylling H, Helve E, et al. Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet 1989;82: 305-7.
27. Tikkanen MJ, Xu CF, Hämäläinen T, et al. XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Genet 1990;37:327-34.
28. Xu CF, Tikkanen MJ, Huttunen JK, et al. Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 1990;31:1255-61.
29. Talmud PJ, Boerwinkle E, Xu CF, et al. Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet Epidemiol 1992;9:249-60.
30. Tikkanen MJ, Heliö T. Genetic variants of apolipoprotein B: relation to serum lipid levels and coronary artery disease among the Finns. Ann Med 1992;24:357-61.
31. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr, Patsch W. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991;49:1145-54.
32. Abbey M, Belling B, Clifton P, Nestel PJ. Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr Metab Cardiovasc Dis 1991; 1:10-2.
33. Friedlander Y, Kaufmann NA, Cedar H, Kark JD. XbaI polymorphism of the apolipoprotein B gene and plasma lipid and lipoprotein response to dietary fat and cholesterol: a clinical trial. Clin Genet 1993;43:223-31.
34. Abbey M, Hirata F, Chen GZ, et al. Restriction fragment length polymorphism of the apolipoprotein B gene and response to dietary fat and cholesterol. Can J Cardiol 1995;11(suppl):79G-85G.
35. Friedlander Y, Berry EM, Eisenberg S, Stein Y, Leitersdorf E. Plasma lipids and lipoproteins response to a dietary challenge: analysis of four candidate genes. Clin Genet 1995;47:1-12.
36. Pajukanta PE, Valsta LM, Aro A, Pietinen P, Heliö T, Tikkanen MJ. The effects of the apolipoprotein B signal peptide (ins/del) and XbaI polymorphisms on plasma lipid responses to dietary change. Atherosclerosis 1996;122:1-10.
37. Humphries SE, Talmud PJ, Cox C, Sutherland W, Mann J. Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge. Q J Med 1996;89:671-80.
38. MacCluer JW, Kammerer CM. Dissecting the genetic contribution to coronary heart disease. Am J Hum Genet 1991;49:1139-44 (editorial).
39. Clarke MJ, Stewart LA. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? In: Chalmers I, Altman DG, eds. Systematic reviews. London: BMJ Publishing Group, 1995:17-36.
40. Rantala M, Savolainen MJ, Kervinen K, Kesäniemi YA. Apolipoprotein E phenotype and diet-induced alteration in blood pressure. Am J Clin Nutr 1997;65:543-50.
41. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
42. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kesäniemi YA. Apolipoprotein B gene DNA polymorphisms are associated with macro-and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 1993;44:177-84.
43. Huang LS, de Graaf J, Breslow JL. ApoB gene MspI RFLP in exon 26 changes amino acid 3611 from Arg to Gln. J Lipid Res 1988;29:63-7.
44. Hallman DM, Visvikis S, Steinmetz J, Boerwinkle E. The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis. Ann Hum Genet 1994;58:35-64.
45. Visvikis S, Chan L, Siest G, Drouin P, Boerwinkle E. An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet 1990;84:373-5.
46. Henkel E, Stolz M. A newly drafted colour test for the determination of triglycerides convenient for manual and mechanized analysis. (Glycerolphosphate-oxidase-PAP method.) Frezenius Z Anal Chem 1982;311:451.
47. Allain C, Poon L, Chan C, Richmond W, Fu P. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470.
48. Lipid Research Clinics. Lipid and lipoprotein analysis. Manual of laboratory operations 1974. Washington, DC: US Department of Health, Education and Welfare, 1975. [US DHEW (NIH) publication 1:75-82.]
49. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
50. Siervogel RM, Morrison JA, Kelly K, Mellies M, Gartside P, Glueck CJ. Familial hyper-alpha-lipoproteinemia in 26 kindreds. Clin Genet 1980;17:13-25.
51. National Center for Biotechnology Information at the National Library of Medicine. World Wide Web: http://www.ncbi.nlm.gov/PubMed/ (accessed December 23, 1999).
52. Hedges LV, Olkin I. Statistical methods for meta-analysis. Montreal: Academic Press, Inc, 1985.
53. Katan MB, Berns MA, Glatz JF, Knuiman JT, Nobels A, de Vries JH. Congruence of individual responsiveness to dietary cholesterol and to saturated fat in humans. J Lipid Res 1988;29:883-92.
54. Aalto-Setälä K, Kontula K, Mänttäri M, et al. DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment. Clin Pharmacol Ther 1991;50:208-14.
55. Aalto-Setälä K, Tikkanen MJ, Taskinen MR, Nieminen M, Holmberg P, Kontula K. XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis 1988;74:47-54.
56. Series J, Cameron I, Caslake M, Gaffney D, Packard CJ, Shepherd J. The Xba1 polymorphism of the apolipoprotein B gene influences the degradation of low density lipoprotein in vitro. Biochim Biophys Acta 1989;1003:183-8.
57. Houlston RS, Turner PR, Revill J, Lewis B, Humphries SE. The fractional catabolic rate of low density lipoprotein in normal individuals is influenced by variation in the apolipoprotein B gene: a preliminary study. Atherosclerosis 1988;71:81-5.
58. Demant T, Houlston RS, Caslake MJ, et al. Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. J Clin Invest 1988;82:797-802.
59. Monsalve MV, Young R, Jobsis J, et al. DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis 1988;70:123-9.
60. Hegele RA, Huang LS, Herbert PN, et al. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 1986;315:1509-15.
61. Genest JJ Jr, Ordovas JM, McNamara JR, et al. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 1990;82:7-17.
62. Lopez-Miranda J, Ordovas JM, Ostos MA, et al. Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 1997;17:1765-73.
63. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile D, Humphries SE. Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease. Atherosclerosis 1989;77:193-201.
64. Ferns GA, Robinson D, Galton DJ. DNA haplotypes of the human apoprotein B gene in coronary atherosclerosis. Hum Genet 1988; 81:76-80.
65. Berg K. Role of genetic factors in atherosclerotic disease. Am J Clin Nutr 1989;49:1025-9.
66. Berg K, Powell LM, Wallis SC, Pease R, Knott TJ, Scott J. Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci U S A 1986;83:7367-70.
67. Berg K. Twin studies of coronary heart disease and its risk factors. Acta Genet Med Gemellol (Roma) 1987;36:439-53.
68. Series JJ, Gaffney D, Packard CJ, Shepherd J. Frequency of the XbaI, EroRI, PvuII and MspI polymorphisms of the apolipoprotein B gene in relation to hypercholesterolaemia in the general population. Clin Chim Acta 1993;215:89-98.
69. Regis-Bailly A, Fournier B, Steinmetz J, Gueguen R, Siest G, Visvikis S. Apo B signal peptide insertion/deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 1995;118:23-34.
70. Peacock RE, Karpe F, Talmud PJ, Hamsten A, Humphries SE. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study. Atherosclerosis 1995;116:135-45.
71. Regis-Bailly A, Visvikis S, Steinmetz J, Fournier B, Gueguen R, Siest G. Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal. Clin Chim Acta 1996;253:127-43.